Subscribe

Heather Landau, MD

Heather Landau, MD, the Memorial Sloan Kettering Cancer Center Amyloidosis Program director

Articles by Heather Landau, MD

Heather Landau, MD, the MSKCC Amyloidosis Program director and the NEXICART-2 principal study investigator

Heather Landau, MD, on Evaluating CAR-T NXC-201 for Light Chain Amyloidosis

By Heather Landau, MD,Noah Stansfield

June 5th 2025

The MSKCC Amyloidosis Program director and NEXICART-2 principal study investigator discussed results she presented at ASCO's 2025 meeting.

Latest Updated Articles

© 2025 MJH Life Sciences^®

All rights reserved.